Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder

Evidence-Based Medicine

Volumn 10, Issue 2, 2005, Pages 46-

  March, J S ^a   Silva, S ^d   Petrycki, S ^d   Dubicka, Bernadka ^b   Ramchandani, Paul ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ADOLESCENT; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR DEPRESSION; OUTPATIENT DEPARTMENT; PATIENT MONITORING; RATING SCALE; RISK ASSESSMENT; SHORT SURVEY; SUICIDE ATTEMPT; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNITED STATES;

EID: 20144388103     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebm.10.2.46     Document Type: Short Survey

References (1)

1. Harrington R, Whittaker K, Shoebridge P, et al. Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. BMJ 1998;316 1559-63.